Financing, Equity Capital Markets

Solid Biosciences Inc.

03/21
|
$143.7 Million
Piper Sandler served as bookrunner for Solid Biosciences, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma